QNT Reclaims the $60 IPO Price as the Quantum Complex Catches a Bid

Reclaiming the $60 Line

For a week the story was simple: $60 priced the IPO, the stock lost it, and every bounce died at a lower high. That just changed. After Quantinuum traded down through the offering price to a low near $51 earlier in the week, QNT climbed roughly 7.5% on June 7 to about $60.51, effectively reclaiming its $60 IPO price. The Hyperliquid perp is tracking it one-for-one, printing $60.71 and up 11.44% over the last 14 hours.

The level itself is the whole point. $60 went from floor — the underwriters' price — to ceiling after the day-two break, and is now back underfoot. The convergence trade is long over; the perp and the cash stock are the same instrument, so this is just the contract following a Nasdaq tape that finally stopped making lower lows. With the pre-IPO book still thin, it doesn't take much size to move it, which cuts both ways. Hold $60 and the post-IPO flush reads like a shakeout; lose it again and the reclaim was noise.

What's Actually Lifting It

This is a sector move, not a Quantinuum headline. The whole quantum complex caught a bid into June 7, helped by a risk-on tape — the Nasdaq rose 1.6% and the S&P 500 added 1.0% — and renewed enthusiasm around Microsoft's quantum-chip progress. The group has been running for weeks; names soared in May on reports the U.S. would take equity stakes and hand out funding across the sector.

QNT has its own peg in that narrative. Quantinuum signed a letter of intent with the Commerce Department's CHIPS office on May 21, part of a $2 billion package spread across nine quantum companies, with $100 million earmarked for Quantinuum. That money is real, but it's weeks old and not net-new today. It's the kind of fundamental anchor traders reach for to justify a bounce that is mostly sentiment and positioning around a defended IPO price.

The Income Statement Didn't Move

Worth keeping the reclaim in proportion: nothing about the business changed between the $51 low and the $60 retake. Quantinuum's first-quarter revenue fell 73% to $5.24 million while its net loss widened to $136.5 million, and the company still carries a roughly $15.7 billion valuation on bookings of about $1.3 million for the quarter. The IPO priced at $60, above its range, and was reportedly more than 20x oversubscribed — the same demand that drove the $71.35 day-one high before reality set in.

So the honest read: this is the IPO anchor being defended in a friendly tape, not evidence the market has re-underwritten the valuation. The $60 line is the tell. Reclaim and hold it, and the flush looks like a washout of weak hands; give it back, and the perp goes right back to tracking a stock that has to grow into a number its income statement is nowhere near.